Mukka Proteins Ltd
Incorporated in 2003, Mukka Proteins
Ltd is a manufacturer and exporter
of Fish Meal and Fish oil[1]
- Market Cap ₹ 771 Cr.
- Current Price ₹ 25.7
- High / Low ₹ 33.3 / 18.3
- Stock P/E 11.2
- Book Value ₹ 16.6
- Dividend Yield 0.00 %
- ROCE 11.6 %
- ROE 11.1 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 63.0 days to 45.2 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Animal Feed
Part of BSE Fast Moving Consumer Goods
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 409 | 549 | 604 | 770 | 1,177 | 1,380 | 1,006 | 1,449 | 1,768 | |
| 385 | 525 | 582 | 723 | 1,091 | 1,274 | 912 | 1,335 | 1,622 | |
| Operating Profit | 23 | 24 | 22 | 48 | 86 | 105 | 95 | 115 | 147 |
| OPM % | 6% | 4.3% | 3.6% | 6% | 7% | 8% | 9% | 8% | 8% |
| 2 | 8 | 10 | 7 | 8 | 19 | 16 | 31 | 31 | |
| Interest | 4 | 7 | 8 | 10 | 16 | 25 | 37 | 54 | 59 |
| Depreciation | 2 | 5 | 8 | 9 | 12 | 12 | 14 | 17 | 18 |
| Profit before tax | 19 | 20 | 15 | 36 | 66 | 87 | 60 | 75 | 100 |
| Tax % | 27% | 31% | 29% | 28% | 28% | 15% | 20% | 24% | |
| 14 | 14 | 11 | 26 | 48 | 74 | 48 | 57 | 74 | |
| EPS in Rs | 1.10 | 2.00 | 2.34 | 1.55 | 1.74 | 2.31 | |||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 7% |
| TTM: | 76% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 53% |
| 3 Years: | 6% |
| TTM: | 59% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -4% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 14% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 22 | 22 | 30 | 30 | 30 |
| Reserves | 38 | 51 | 61 | 76 | 126 | 366 | 411 | 469 |
| 83 | 142 | 159 | 175 | 262 | 365 | 453 | 779 | |
| 74 | 95 | 129 | 119 | 166 | 179 | 183 | 343 | |
| Total Liabilities | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
| 49 | 78 | 79 | 83 | 85 | 85 | 94 | 194 | |
| CWIP | 0 | 2 | 4 | 0 | 0 | 0 | 9 | 31 |
| Investments | 8 | 4 | 12 | 21 | 21 | 31 | 37 | 56 |
| 144 | 209 | 260 | 289 | 469 | 825 | 937 | 1,341 | |
| Total Assets | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| -20 | -25 | 2 | 5 | -56 | -150 | -112 | -111 | |
| -23 | -28 | -14 | -11 | -3 | -48 | -35 | -146 | |
| 34 | 54 | 13 | 15 | 75 | 266 | 56 | 267 | |
| Net Cash Flow | -9 | 1 | 2 | 8 | 15 | 68 | -91 | 10 |
| Free Cash Flow | -39 | -61 | -8 | -1 | -64 | -165 | -130 | -230 |
| CFO/OP | -67% | -81% | 29% | 22% | -52% | -118% | -114% | -84% |
Ratios
Consolidated / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 23 | 29 | 29 | 35 | 49 | 72 | 46 |
| Inventory Days | 95 | 89 | 106 | 95 | 89 | 136 | 266 | 267 |
| Days Payable | 63 | 63 | 71 | 56 | 51 | 44 | 67 | 75 |
| Cash Conversion Cycle | 57 | 49 | 64 | 68 | 73 | 141 | 272 | 238 |
| Working Capital Days | 4 | -9 | -12 | -1 | 10 | 45 | 99 | 45 |
| ROCE % | 15% | 9% | 18% | 24% | 19% | 12% | 12% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Export Revenue Share % |
|
|||||
| Number of Customers Served count |
||||||
| Fish Meal Capacity Utilization % |
||||||
| Fish Meal Installed Capacity MT/year |
||||||
| Fish Meal Production Volume MT |
||||||
| Fish Oil Production Volume MT |
||||||
| Top 10 Customer Concentration % |
||||||
| Insect Protein Wet Waste Processed Tons |
||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
- 51% Aqua Marine acquisition for up to Rs 15 crore delayed to 31 January 2027.
-
Closure of Trading Window
- Trading window closes from 1 October 2026 until 48 hours after Q2 FY2027 results.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Suraag Capital virtual one-on-one investor meeting rescheduled to 29 September 2026.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
Business Overview:[1]
The company is one of India's largest manufacturers and exporters of fishmeal,
fish oil and fish soluble paste, holding an estimated 25–30% share of India's fishmeal/fish-oil segment by revenue and has evolved into a four-vertical platform spanning
-Fish Protein
-Alternate (Insect) Protein
-Waste Management & Environmental Solutions
-Frozen & Value-Added Marine Products.